United States · Funded startup
4 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$176Mraised across 4 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $20M sold, first sale Nov 2014
Goldman Sachs
T. Rowe Price
Sigma Capital Group Plc
Och-Ziff Capital Management
Rosewood CorporationReported by fibrogen.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
NovaQuestLGoldman SachsT. Rowe PriceAdage Capital ManagementBrookside CapitalJanus Capital GroupBioFund ManagementMerlin BiomedSigma Capital Group PlcApothecary CapitalMissing a round, or an investor who was in one? Tell us.
This firm lists FibroGen as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
FibroGen's investors include NovaQuest, Goldman Sachs, T. Rowe Price, Adage Capital Management and Brookside Capital, and 11 more on record. NovaQuest led its latest round.
FibroGen has raised $176M across 4 rounds since 2005.
FibroGen's most recent round was a Debt of $50M in Nov 2022, led by NovaQuest.
FibroGen's largest round on record is $100M (Series F), in Feb 2005.
FibroGen's first round on record, in Feb 2005, was backed by Goldman Sachs, T. Rowe Price and Adage Capital Management and 12 others.
FibroGen's latest named round is a Debt, in Nov 2022.
FibroGen is based in the United States.
NovaQuest led the Debt in 2022.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
